Report Details:
15 Companies Covered
153 Pages
Market Research Future (MRFR) has published a comprehensive research report on the Global Bronchoscopes Market, covering the forecast period from 2026 to 2035. According to the analysis, the Bronchoscopes Market was valued at USD 4.69 Billion in 2025 and is projected to grow significantly, reaching USD 9.81 Billion by 2035, registering a compound annual growth rate (CAGR) of 7.65% during the forecast period.
MRFR identifies Olympus Corporation, Karl Storz SE, Fujifilm Holdings, Ambu A/S, Boston Scientific Corporation, Medtronic plc, Pentax Medical (HOYA Corporation), Johnson & Johnson (Auris Health), Intuitive Surgical, Richard Wolf GmbH, and Verathon (Roper Technologies) as the key players operating in the Global Bronchoscopes Market.
Market Highlights
The Global Bronchoscopes Market is accounted for to register a CAGR of 7.65% during the forecast period and is estimated to reach USD 9.81 Billion by 2035.
One of the primary factors driving the market growth is the increased acceptance of lung cancer screening programs. The rising prevalence of lung cancer coupled with expanding screening eligibility is increasing bronchoscopy procedure volumes globally, resulting in robust demand for sophisticated diagnostic and therapeutic bronchoscopes.
There is an increasing trend to single-use bronchoscopes and this is having a major impact on the industry. Increasing concerns surrounding cross-contamination, infection control and the expenses related to hospital reprocessing are prompting healthcare institutions to shift their focus from reusable systems to disposable devices, especially in intensive care units and outpatient settings.
Technology developments including high-definition digital imaging, robotic-assisted bronchoscopy, and AI-enabled navigation systems are altering the market landscape. These technologies improve diagnostic accuracy, streamline physician processes and improve access to peripheral lung lesions, while also generating recurring income potential with software and consumables.
In addition, favorable reimbursement policies including CMS HCPCS C1601 pass-through payments in the U.S., growing use of ambulatory surgery centers, and developing healthcare infrastructure in emerging nations are driving long-term market growth.
Segment Analysis
The Global Bronchoscopes Market is segmented based on Product Type, Usage, Application, and End User.
By Product Type, the market includes Flexible Bronchoscopes, Rigid Bronchoscopes, and Accessories. Flexible Bronchoscopes hold the largest market share, accounting for 66.5% in 2025 due to their versatility across diagnostic and therapeutic procedures. Rigid Bronchoscopes are the fastest-growing segment within interventional pulmonology, supported by increasing airway stenting and foreign-body removal procedures.
By Usage, the market includes Reusable Bronchoscopes and Single-Use Bronchoscopes. Reusable Bronchoscopes dominated the market with a 69.6% share in 2025 owing to their lower long-term procedural costs. Single-Use Bronchoscopes are the fastest-growing segment, registering a CAGR of 17.0% through 2035 as hospitals increasingly prioritize infection prevention and simplified workflow.
By Application, the market includes Oncology, Pneumonia & Infection Diagnosis, and ICU Airway Management. Oncology accounted for the largest market share at 39.0%, driven by rising global lung cancer incidence and increasing tissue biopsy procedures. ICU Airway Management is the fastest-growing segment, supported by expanding critical care infrastructure and higher intensive care admissions.
By End User, the market includes Hospitals and Ambulatory Surgical Centers (ASCs). Hospitals dominate the market due to higher procedure volumes, advanced interventional capabilities, and capital equipment investments. Ambulatory Surgical Centers represent the fastest-growing segment as healthcare systems increasingly shift diagnostic procedures toward lower-cost outpatient care settings.
Region Analysis
Regionally, the Global Bronchoscopes Market is experiencing steady growth across major regions, supported by technological innovation, favorable reimbursement policies, and expanding respiratory disease diagnostics.
North America accounted for the largest market share of 44.5% in 2025, driven by widespread robotic bronchoscopy adoption, strong reimbursement frameworks, and increasing utilization of single-use bronchoscopes across hospitals and ambulatory centers.
Europe represents the second-largest regional market, contributing approximately USD 1.27 Billion in 2025. Growth is supported by compliance with the EU Medical Device Regulation (MDR), rising investments in advanced bronchoscopy platforms, and increasing adoption of disposable devices to improve infection control.
Asia-Pacific is expected to be the fastest-growing regional market, registering a CAGR of 10.2% during the forecast period. National lung cancer screening initiatives across China, Japan, South Korea, and India, combined with hospital infrastructure expansion and rising healthcare expenditure, continue to accelerate market growth.
The Middle East & Africa is emerging as a high-growth market, driven by large-scale healthcare infrastructure investments, expanding hospital construction projects, and increasing demand for respiratory diagnostic equipment. South America is also witnessing steady growth, supported by public healthcare modernization and increasing procurement of bronchoscopy systems.
Key Findings of the Study
- The Global Bronchoscopes Market is projected to grow at a CAGR of 7.65% during the forecast period.
- The market is expected to reach USD 9.81 Billion by 2035, driven by expanding lung cancer screening programs and growing adoption of single-use bronchoscopes.
- Flexible Bronchoscopes accounted for the largest market share, while Single-Use Bronchoscopes are the fastest-growing usage segment.
- Oncology dominated the application segment, while ICU Airway Management is expected to witness the highest growth during the forecast period.
- North America accounted for the largest market share, while Asia-Pacific is projected to be the fastest-growing regional market.
- Olympus Corporation, Karl Storz SE, Fujifilm Holdings, Ambu A/S, Intuitive Surgical, and Johnson & Johnson (Auris Health) continue to drive technological innovation and competition in the global market.
